Chugai Pharmaceutical Included in Roche’s 2024 Results
Company Announcements

Chugai Pharmaceutical Included in Roche’s 2024 Results

Chugai Pharmaceutical Co (JP:4519) has released an update.

Chugai Pharmaceutical Co. reports that its performance for the first half of 2024 has been included in the half-year results announced by its parent company, Roche Holding Ltd. Roche, which owns 59.89% of Chugai’s issued shares and 61.12% of its voting rights, released these results covering January to June 2024. Investors can access further details on Roche’s website.

For further insights into JP:4519 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Japan Auto-Generated NewsdeskChugai Pharmaceuticals Revises Financial Forecasts
TipRanks Japan Auto-Generated NewsdeskChugai Pharmaceutical Boosts 2024 Revenue Forecast
TipRanks Japan Auto-Generated NewsdeskChugai Pharmaceutical Reports Strong Financial Growth in 2024
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App